Wordt geladen...
The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker
Leukemic cells display some alterations in metabolic pathways, which play a role in leukemogenesis and in patients’ prognosis. To evaluate the characteristics and the impact of this metabolic reprogramming, we explore the bone marrow samples from 54 de novo acute myeloid leukemia (AML) patients, usi...
Bewaard in:
Gepubliceerd in: | Blood Adv |
---|---|
Hoofdauteurs: | , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Hematology
2021
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805315/ https://ncbi.nlm.nih.gov/pubmed/33570627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002981 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|